Preparation and Culture of chondrocyte/agarose constructs
Embryonic mouse chondrocytes were isolated from the ventral parts of the rib cages of 17.5 dpc mice. For each experiment, cells were pooled from all embryos from 2 or 3 OF-1 mouse litters. Mouse care and treatment were conducted in conformity with institutional guidelines in compliance with national and international laws and policies (Authorization n°69387416 given by the French Prefecture du Department du Rhone). Agarose hydrogels were prepared by mixing 2.5% low melting agarose (Seaplaque, Cambrex BioScience) with 5 × Dulbecco's modified Eagle's medium/Ham's F-12 (DMEM/F-12) containing 10% FBS, 50 mM Hepes and 500 U/mL Penicillin and 500 μg/mL Streptomycin (all products from Gibco). Cells were suspended in this agarose solution with a density of 2 × 106 cells/mL. 700 μL of the mixture was poured into wells of 24-well plates, and chondrocyte/agarose constructs were allowed to gel at room temperature. Constructs were then punched to obtain cylindrical gels (13 mm diameter and 3 mm height) that were placed into wells of Biopress™ compression plates (Flexcell international), within the 13 mm diameter foam ring (Figure ). A volume of 4 mL DMEM/F-12 culture medium containing 10% FBS and 100 U/mL Penicillin and 100 μg/mL Streptomycin was added to each well. The cell/agarose constructs were maintained in culture for 6 days in 5% CO2 at 37°C. The culture medium was changed every day with a progressive deprivation of serum as detailed in Table .
Compression
Samples were submitted to load with FX-4000C™ Flexercell® Compression Plus™ System (Flexcell International). The strain regimen consisted either in (i) cyclical compression with pulses of 20 kPa at a frequency of 0.33 Hz (2 sec on, 1 sec off) superimposed on 20 kPa static offset pressure for 30 min, or in (ii) intermittent compression of 30 kPa using a sinusoid waveform at 0.2 Hz for 30 min, as indicated (Figure ). As control, cell/agarose constructs were maintained under uncompressed conditions.
Immunohistochemistry
The chondrocyte/agarose constructs were fixed in 4% formaldehyde for at least 24 h, after which they were embedded in Paraffin, sectioned at 7 μm, and then deparaffinised. Prior to antibody treatment, the sections were sequentially incubated with hyaluronidase (Sigma, type I-S, 800 U/mL) for 1 h at 37°C and 0.1% Triton X-100 for 20 min at room temperature. The sections were then incubated overnight with 2B1 anti-type II collagen primary mouse antibody (kind gift from Richard Mayne) [
29] at 4°C. After washing in Phosphate Buffer Saline, the sections were incubated with Cy™2-conjugated AffiniPure donkey anti-mouse IgG (Jackson Immunoresearch) for 1 h at room temperature.
Protein Extraction and Analysis
At the different time points studied the chondrocyte/agarose constructs were frozen in liquid nitrogen, freeze-dried and stored at -20°C until analysis. For protein extraction, 4 × Laemmli buffer was prepared (250 mM Tris-HCl, 20% glycerol, 10% SDS and bromophenol blue) and extemporaneously diluted to 1 × and supplemented with 3% 2-mercaptoethanol. A volume of 200 μL of this extraction buffer was added to each freeze-dried construct and the mixture was boiled immediately for 5 min. The lysates were allowed to gel at room temperature before being transferred on paper filter mini-spin columns (Pierce) and centrifuged at 12,000 g for 1 h at room temperature. The exudates were collected in mini-tubes and stored at -20°C until further analysis by Western blotting. The antibodies used in this study are described in Table .
| Table 2Antibodies used for Western blot analysis |
RNA Extraction
The protocol of RNA extraction was modified from the RNeasy-mini kit (Qiagen) procedure. Briefly, each chondrocyte/agarose construct was diced in a mixture of 1.5 mL QG buffer (Qiagen) and 2 mL RLT buffer (Qiagen kit) and the samples were kept at room temperature until complete dissolution, and then stored at -20°C. After defrosting, the samples were homogenized and supplemented with 2 mL 70% ethanol. The subsequent RNA purification steps were performed as described by the manufacturer. RNA quantity and quality were assessed by using a capillary electrophoresis system (RNA Nano kit and 2100 BioAnalyzer, Agilent).
Reverse transcription and Real time PCR
Reverse transcription (RT) was performed as described [
20]. For real time PCR amplification, a 20 μL reaction contained 1.3 μL of RT product, 10 μL SYBR green Supermix (Bio-Rad) in the presence of 300 nM of specific primers (see Table ). Amplification was performed in an iCycler iQ (Bio-Rad), using the following conditions: an initial denaturation step of 2 min at 95°C, followed by 40 cycles of 30 sec at 95°C, 30 sec at 54°C, and an extension step of 3 min at 72°C. Levels of gene expression were determined by using the comparative
Ct method with
RPL13a gene as endogenous control.
| Table 3Primers used for real time PCR analysis |
Transfection
Prior to transfection, chondrocytes were amplified in monolayer culture for one week. After trypsinization, 3 × 106 cells were suspended in 100 μL of electroporation buffer and mixed with 4 μg plasmid of interest and 1 μg plasmid encoding β-galactosidase. The plasmids were transfected by using the Human Chondrocyte Nucleofector kit (Amaxa) according to the manufacturer's protocol (Program U-24). Although nucleofection leads to about 60% cell mortality, this method provides high transfection efficiency (around 80%) for the viable cells. This transfection efficiency was assessed by monitoring synthesis of green fluorescent protein in chondrocytes observed under a fluorescence microscope, after transfection of the corresponding expression vector (data not shown).
Measure of COL2A1 promoter activity
Immediately after nucleofection, chondrocytes were embedded in agarose and the cell/agarose constructs were submitted to compression the following day. At the end of the compression regimen (20 h post-transfection), the constructs were frozen in liquid nitrogen and stored at -80°C. The frozen samples were then freeze-dried for 12 h before being grinded in TissueLyser (Qiagen) for 1 min at 20 Hz. The resulting powder was rehydrated in 200 μL of the kit lysis solution for 1 h at 4°C and reporter assays were performed using Dual-Light® combined reporter gene assay system for detection of luciferase and β-galactosidase (Applied Biosystems), as described by the manufacturer, and MLX™ Microtiter® plate luminometer (Dynex). COL2A1 promoter activity was obtained as a ratio of luciferase to β-galactosidase luminescence.
Quantification and statistical analysis
For Western-blotting analysis, band intensity was quantified by densitometry using ImageQuant software (v5.2, Molecular Dynamics). The ratio of phospho-MAPK to total-MAPK band intensity was calculated and mechanically-induced phosphorylation was normalized to uncompressed controls. For the analysis of the compression effects on mRNA levels and promoter activity, data represent the mean and standard deviation values of 3 independent experiments. Statistical analysis was performed using a Student's paired, two-tailed t-test. Significance was reported at the 90% (*) or 95% (**) confidence level.